Burning Rock Biotech Ltd-adr (BNR) — Who Owns This Stock? 13F Breakdown (Q2 2026)

BNR ranks #8789 out of 37503 tracked stocks by institutional interest, inside the more closely watched half of our coverage.

BNR is a disclosed holding of Jim Simons (Renaissance Technologies), one of the tracked superinvestors on AlphaSMO — it makes up 0.0% of that fund's own 13F portfolio.

17 institutions disclose a position in BNR, but none treat it as a major bet — even Crcm LP, its most concentrated holder, allocates just 1.2% of its own portfolio to it.

Morgan Stanley has added to its BNR position for two straight quarters, increasing it by $126.3K to reach $364.9K today.

Kynam Capital Management, LP has trimmed its BNR position for two straight quarters, cutting it by $9.5M while still holding $10.5M.

BNR reported a net loss of $55.3M in its latest fiscal year.

• Not yet profitable — net loss of $55.3M in the latest fiscal year
• Revenue grew 4.6% year over year
• Net income improved year over year, from -$346.6M to -$55.3M
• Operating cash flow was negative, using $28.4M in cash
• Current ratio of 2.99x — enough short-term assets to cover short-term liabilities
• Liabilities run 0.53x equity — within a conventional range